跳至主要内容
临床试验/JPRN-UMIN000018673
JPRN-UMIN000018673已完成未知

Investigation of the effectiveness of whole wheat bread intake for 12 weeks against metabolic syndrome index: Effects on visceral fat area, fasting blood glucose and serum lipids. - Investigation of the effectiveness of whole wheat bread intake for 12 weeks against metabolic syndrome index.

CPCC Company Limited0 个研究点目标入组 50 人开始时间: 2015年8月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects who have continuous intake of Divaricate Saposhnikovia Miraculous Powder. (2) Subjects who take drugs to treat dyslipidemia. (3) Subjects who experienced body weight changes >= 10% within a year before the start date of this study. (4) Fasting blood glucose >=126 mg/dl or HbA1c (NGSP) >=6.5% or diabetic patient. (5) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). (6) Subjects who have history of surgery in gastrointestinal tract. (7) Subjects who have history of malignant diseases. (8) Females who are pregnant or lactating, and who could become pregnant or lactating during test period. (9) Subjects who have excessive alcohol intake. (10) Subjects who have extremely irregular dining habits, and who have midnight work or irregular shift work. (11) Subjects who have continuous intake of dietary fiber supplement or whole grain. (12) Subjects who have serious infectious diseases. (13) Subjects who have previous medical history of drug and/or food allergy. (14) Subjects who are participating in other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate in other clinical tests. (15) Subjects who donated over 200mL blood and/or blood components within the last one month. (16) Males who donated over 400mL blood within the last three month. (17) Females who donated over 400mL blood within the last four month. (18) Males who will be collected over 1200 mL of blood when the planned sampling volume in this study is added to the volume collected within the last 12 months. (19) Females who will be collected over 800 mL of blood when the planned sampling volume in this study is added to the volume collected within the last 12 months. (20) Subjects who are not eligible for this study for some medical reasons.

研究者

发起方
CPCC Company Limited

相似试验